Presentation on theme: "Adolf E. Schindler PRIZEWINNER OF PROFESSOR IOSEB JORDANIA INTERNATIONAL PRIZE-2007 PROGESTERONE AND PROGESTINS IN PREGNANCY: DIAGNOSTIC AND THERAPEUTIC."— Presentation transcript:
Adolf E. Schindler PRIZEWINNER OF PROFESSOR IOSEB JORDANIA INTERNATIONAL PRIZE-2007 PROGESTERONE AND PROGESTINS IN PREGNANCY: DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS Institute for Medical Research and Education, Essen, Germany
Progesterone is essential for implantation and maintenance of pregnancy. Progesterone is the dominant hormone throughout pregnancy. Among the manifold actions progesterone is essential for the protection of the allogenic conceptus from immunological rejection by the mother. At first, production and secretion of progesterone is determined by placental HCG. However, later progesterone continuous to rise throughout pregnancy independent from the HCG serum levels. Indeed, there is at the beginning of pregnancy a HCG-doubling time, which is prolonged in pregnancy failure (orthotopic as well as ectopic).
Lack of normal HCG-doubling time indicates: Ectopic location of the gestation Trophoblast abnormalities Disturbed placentation Genetic aberrations
It is important to note that there is a luteal-placental shift around week 8 to 10 of gestation, which can be associated with a decrease of circulating amount of progesterone and this can lead to bleeding, uterine contractions and finally to abortion. The renewed increase indicates placental progesterone production, since the Corpus luteum function fades away.
The major endocrine causes of spontaneous or recurrent abortions are: 1.Corpus luteum insufficiency 2.Defective luteo-placental-shift 3.Placental insufficiency.
Which clinical conditions may be effectively treated by progesterone or progestins? 1.Spontaneous abortions 2.Habitual abortion 3.Premature labor 4.Hypertension in pregnancy
At present the following preparations are available for clinical use in pregnancy: 1.Micronized progesterone (vaginal) 2.Dydrogesterone (Oral) Duphaston® 3.17-a Hydroxyprogesterone caproate (i.m.) Treatment schedules for the various clinical conditions will be outlined and the results discussed.
90 CME credits Intercontinental Academy of Medical-Social Sciences (IAMSS) OGASH Number 90 (ninety) IAMSS International CME credits are recognized by Post Congress IAMSS OGASH Awards Commission Chairperson, IAMSS Presidium Chairperson, Hon. Academician of OGASH, Academician Secretary of OGASH Prof / Dr IRMA de LUCA BRUNORI MD., PhD. Verified the achievement & award of the proceeding author Adolf E. Schindler Post Congress IAMSS OGASH Awards Commission Chairman, IAMSS Presidium Chairperson, Post Congress IAMSS OGASH Awards Commission Chairman, IAMSS Presidium Chairperson, Hon. Academician of OGASH Academician Prof./Dr. Malkhaz Mizandari MD., PhD. Academician Prof./Dr. Malkhaz Mizandari MD., PhD. CERTIFIES the achievement of n. 90 International credits (IAMSS )